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Abstract: A convenient method for the synthesis of pyrido[2,3-d]pyrimidines by using the novel 
nanomagnetic silica-bonded S-sulfonic acid [Fe3O4@SiO2@(CH2)3S-SO3H] as an efficient and 
recyclable catalyst under solvent free condition is described. The major advantages of the present 
methodology are high yield, short reaction time, and reusability of the catalyst. Furthermore, the 
nanomagnetic silica-bonded S-sulfonic acid was fully characterized by using various techniques 
such as FT-IR, TG/DTG, DTA, EDX, μXRF, µXRF elemental mapping, XRD, HRTEM, SEM, 
XPS, and N2 physisorption. The results obtained from this research support the idea of rational 
designs, syntheses, and applications of tasked-specific and reusable catalysts for the synthesis of 
various polynitrogenated heterocyclic compounds containing 1,4-dihydropyridine moieties. 
Keywords: Tasked-specific catalyst, Reusable catalyst, Nano magnetic silica-bonded S-sulfonic 
acid, Solvent free conditions, Pyrido[2,3-d]pyrimidines, Nitrogen heterocyclic compounds, 1,4-
Dihydropyridines. 
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Introduction 
Nowadays, the design of safer chemicals and chemical processes is of great interest.1 In this sense, 
catalytic processes play a major role in environmental protection by reducing toxic waste and 
reaction times while keeping high yield conditions. Solid acids are known as important catalysts 
in a wide range of reactions because of their high activity and recyclability.2 Among them, 
magnetic nano-catalysts are even more attractive due to their easy and fast separation from reaction 
media. 
Nitrogenated heterocyclic compounds are invaluable candidates for the design and discovery of 
new biologically active compounds. Well-known examples are those molecules with 1,4-
dihydropyridine (1,4-DHP) moieties which are considered as ‘distinguished scaffolds’ due to their 
bio- and pharmaceutical activities. Among them, 1,4-dihydropyridine derivatives are calcium 
channel blockers, cardiovascular agents for the treatment of hypertension,3 antivirals,4 
antioxidants,5 and anti-tumorals.6,7 Therefore, 1,4-DHPs are good candidates for drug components, 
having been their syntheses and applications extensively reviewed.8 Another remarkable feature 
of 1,4-DHPs as Hantzsch esters is their use as NAD(P)H (I) analogues (Figure 1) for the catalytic 
hydrogenation of unactivated aldehydes 9,10 and 1,2,4-triazolinediones.11 
Regarding synthetic methodologies towards 1,4-dihydropyridines, Li et al. have recently 
synthesized pyrido[2,3-d]pyrimidines via a one-pot three component reaction of aromatic 
aldehydes, malononitrile, and 2,6-diaminopyrimidin-4-one using [bmim]BF4 as solvent at 80 oC.12 
To the best of our knowledge, this is the only methodology towards pyrido[2,3-d]pyrimidines 
reported so far. Thus, the development of new and simple organic synthetic methods for the 
efficient preparation of this type of heterocycles is an interesting challenge in this field. 
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Figure 1: The molecular structure of NADH 
Niknam et al. have reported the synthesis and application of a bulky, amorphous silica-bonded S-
sulfonic acid (SBSSA) as a reusable catalyst for the preparation of aromatic 1,1-diacetates,13 
quinoxalines,14 4,4'-(arylmethylene) bis (1H-pyrazol-5-ols),15 α-amino nitriles,16 1,8-dioxo-
decahydroacridines, 1,8-dioxo-octahydroxanthenes,17 bis (indolyl) methanes,18 silylated 
alcohols,19 trisubstituted dimidazoles,20 2,3-dihydroquinazolin-4(1H)-ones21, and 2-aryl-1-
arylmethyl-1H-1,3-benzimidazoles.22 
A proper design, synthesis, and application of a given catalyst must consider important aims, such 
as recyclability, reusability, and proper tasked-specific behavior. Herein, following our recent 
interest on the rational design and synthesis of dihydropyridine derivatives for the development of 
new biomimetic reactions,23 we wish to report an operative and one-pot synthetic method for the 
preparation of pyrido[2, 3-d]pyrimidines using novel magnetic nano particles of 
[Fe3O4@SiO2@(CH2)3S-SO3H] as a recyclable and reusable catalyst under neat conditions 
(Schemes 1 and 2). 
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Scheme 1. Synthesis of magnetic nano catalyst [Fe3O4@SiO2@(CH2)3S-SO3H] 
 
Scheme2. Synthesis of pyrido[2,3-d]pyrimidines 6a-p promoted by magnetic nanocatalyst 2.  
Results and discussion  
Fe3O4@SiO2 nanoparticles and [Fe3O4@SiO2@(CH2)3S-SO3H] were synthesized following the 
procedure previously reported by our research group (Scheme 1).24a  To ensure construction of the 
recoverable magnetic nanoporous catalyst 2, this material was analyzed using different techniques 
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such as, Fourier transforms infrared spectroscopy (FT-IR), thermal gravimetric (TGA), derivative 
thermal gravimetric (DTG), differential thermal analysis (DTA), energy-dispersive X-ray 
spectroscopy (EDX), micro X-ray fluorescence (μXRF), µXRF elemental mapping, X-ray 
diffraction patterns (XRD), high resolution transmission electron microscopy (HRTEM), scanning 
electron microscopy (SEM), N2 physisorption, and X-ray photoelectron spectroscopy (XPS) 
(Figures 2-9). 
The FT-IR spectrum of the synthesize [Fe3O4@SiO2@(CH2)3S-SO3H] nano catalyst 2 was 
investigated and compared with the precursor material [Fe3O4@SiO2@(CH2)3SH] 1 (Figure 2). As 
shown, both materials showed the corresponding Si-Si stretching absorption bands at 1077 and 
1104 cm-1, respectively. In the case of 2, the broad absorption band at 1077 overlapped the 
symmetric stretching absorption band from the SO2 moiety. 
 On the other hand, catalyst 2 also showed two more absorption bands at 649 and 1206 cm-1, 
corresponding to the stretching vibration of the S-O bond and the asymmetric stretching vibration 
of the SO2 group (Figure 2b). 
 
Fig. 2. FT-IR spectrum of two final steps a) Fe3O4@SiO2@(CH2)3SH] and b) [Fe3O4@SiO2@(CH2)3S-SO3H] 
(a) 
(b) 
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In order to monitor the thermal stability and behavior of [Fe3O4@SiO2@(CH2)3S-SO3H], the 
thermogravimetry (TG), derivative thermogravimetry (DTG), and the differential thermal analysis 
(DTA) were conducted being the attained data depicted in Figures 3 and 4. Regarding TGA, the 
first weight loss step, related to the removal of surface-adsorbed water and organic solvents, took 
place between 25 and 105 °C and involved a weight loss of 4 wt%. Finally, the second and main 
weight loss region for [Fe3O4@SiO2@(CH2)3S-SO3H] (between 105 to 700 °C) could be ascribed 
to the continuing decomposition of  the sulfur moieties of the catalyst. The weight loss for this step 
was calculated to be 28.7% which was clearly correlated with μXRF results (see Figure 5). The 
remaining 71.3 wt% of catalyst was attributed to the Fe3O4@SiO2. Moreover, the DTA analysis 
diagram showed a general negative downward slope between 25 °C to 700 °C in which, 
decomposition of catalyst and its precursor in nitrogen atmosphere were exothermic (Figure 4). 
 
Fig. 3. Thermal gravimetric analysis (TG/DTG) analysis of nano [Fe3O4@SiO2@(CH2)3S-SO3H] 
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Fig. 4. Differential thermal analysis (TG/DTA) of nano [Fe3O4@SiO2@(CH2)3S-SO3H] 
Next, micro X-ray fluorescence (µXRF), µXRF elemental mapping and energy-dispersive X-ray 
spectroscopy (EDX) analyses were used to determine the organic content and also the elemental 
composition of the nano-catalyst 2 (Figures 5a-f). As shown in Figure 5, the EDX and µXRF of 2 
confirmed the presence of the expected elements in the catalyst structure, with a 29.44 wt% of 
sulfur content. Examination of the µXRF mapping images (Figures 5c-f) proved the presence of 
Si, Fe, and S elements in the catalyst with a good distribution over the catalyst surface. 
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Fig. 5. (a) Micro X-ray fluorescence (µXRF) quantitative results (b) SEM-EDX (c) µXRF image and µXRF 
elemental mapping images of (d) silisium (red), (e) sulfur (green), (f) iron (blue) of nano catalyst 
[Fe3O4@SiO2@(CH2)3S-SO3H]. 
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The particle size and shape as well as the morphology of nanoporous catalyst 2 were studied by 
XRD, SEM, and HRTEM (Figures 5-7 and Table 1). Characterization by X-ray diffraction (XRD) 
was performed to investigate the crystalline structure of [Fe3O4@SiO2@(CH2)3S-SO3H] in a range 
of 10 < 2θ < 80° (Figure 5). On the other hand, XRD patterns demonstrated diffraction lines of 
high crystalline nature at 2θ = 18.00°, 30.30°, 35.50°, 43.60°, 54.00°, 57.30°, 62.70° and 74.60° 
corresponding to Fe3O4 diffraction lines (111), (220), (311), (400), (422), (511), and (440) (Figure 
6) [24a]. The peaks in range of 20 to 29 are related to Si [25], indicating this shift a proper progress 
in the catalyst preparation. Furthermore, the average crystalline size D (nm) of 2 could be estimated 
according to the Scherrer equation D = Kλ/(β cos θ), where λ is the X-ray wavelength of Cu kα 
(1.54Å), K is the Scherrer constant with a value of 0.9, β is the peak width at half maximum 
(FWHM) of the peak in radians, and θ is the Bragg diffraction angle. On the other hand, the 
averaged inter-planar distance [nm] of 2, 0.49279 nm (sing the similar highest diffraction line at 
18.0o), was calculated according to the Bragg equation: dhkl = λ/(2sinθ), where K is a shape factor 
with the value of 0.9, θ is the Bragg diffraction angle, λ is the wavelength of Cu kα (1.5405 Å) as 
the X-ray source. Crystalline sizes from various diffraction lines using the Scherrer equation were 
found to be in the nanometer range (29.06 - 47.31 nm), which is in a close agreement with the 
scanning electron microscopy (SEM) results. 
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Fig. 6. XRD pattern of nano [Fe3O4@SiO2@(CH2)3S-SO3H] 
Table 1. X-ray diffraction (XRD) data for nano catalyst [Fe3O4@SiO2@(CH2)3S-SO3H] 
Entry 2θ Peak width [degree] Size [nm] Inter planar distance [nm] 
1 18.00 0.1 82.54 0.49279 
2 30.30 0.1 84.4 0.29497 
3 35.50 0.5 16.73 0.25286 
4 43.60 0.1 87.81 0.20758 
5 57.30 0.3 30.37 0.16078 
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6 62.70 0.1 95.46 0.14817 
7 74.60 0.2 49.78 0.12721 
Studies by SEM and HRTEM spectroscopy (Figure 7), helpful techniques to provide information 
about particle size and morphology of the materials, showed well-dispersed nanospherical particles 
with a high yield with an average size of 85 nm. 
 
Fig. 7. (a) High resolution transmission electron microscopy (HRTEM) and (b) Scanning electron microscopy 
(SEM) of nano magnetic [Fe3O4@SiO2@(CH2)3S-SO3H] 
Next, Nitrogen adsorption/desorption isotherm was carried out to obtain the information on 
the porosity and total surface area of the catalyst 2. As shown in Figure 8a, the studied catalyst 
exhibited type II isotherm according to the IUPAC definition and with H3 type hysteresis loop, 
which indicated the presence of a nanoporous structure. The surface area and pore volume of 
the catalyst are listed in Table 2. Moreover, a narrow pore-size distribution was calculated 
from the adsorption branch on the basis of BJH model (Figure 8b). 
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Fig. 8. (a) N2 physisorption isotherm and (b) BJH pore size distribution of the [Fe3O4@SiO2@(CH2)3S-
SO3H] 
Table 2. Textural properties of the [Fe3O4@SiO2@(CH2)3S-SO3H] 
SBETa  
(m2g-1) 
SBJHb  
(m2g-1) 
Vmc 
(cm3g-1) 
Vtd  
(cm3g-1) 
De  
(nm) 
44.36 31.56 0.10 0.08 3.05 
a SBET: total surface area. b SBJH: surface area estimated by BJH model applied to the absorption branch of 
the isotherm. c Vm: mesopore volume. d Vt: total pore volume. e D: pore diameters estimated by BJH model 
applied to the absorption branch of the isotherm.  
X-ray photoelectron spectroscopy (XPS) studies were next performed over 
[Fe3O4@SiO2@(CH2)3S-SO3H] in order to get insight about the surface composition and changes 
14 
 
associated with the chemical reaction of this catalyst (Figure 9). As expected, the peaks 
corresponding to S2p, O1s, C1s, Fe2p, and Si2p were clearly seen in the XPS survey spectrum of 
cat 2, which confirmed a 3-(trimethoxysilyl)-1-propanethiol moiety covalently bonded to 
Fe3O4@SiO2 (Figure 9a). As shown in Scheme 1, there are two types of sulfur containing groups, 
sulfide (-S-S-) as a covalent bridge bond and sulfate (-SO3) as an active catalytic site. Therefore, 
the high resolution XPS spectrum of S2p was used as a potential technique for the analysis of both 
internal and terminal sulfurs on catalyst 2. As shown in Figure 9b, the S2p spectrum comprises 
two singlet binding energy located at approximately 163.32 eV (S-S) and 168.88 eV (SO3H) with 
a relative peak area ratio (1:5) respectively. Each S2p peak could be de-convoluted into the two 
different peaks located at approximately 163.32, 168.88 eV, corresponding to 2p3/2 and 164.838, 
169.94 eV, which corresponded to 2p1/2 level. Interestingly, the relative area between S-S and S-
O/S=O were not same indicating that the surface of catalysts was covered with thiosulfonate 
groups [25]. On the other hand, the XPS peak for chloride was not detected, (Figure 8b, orange 
lines), and only an orange residuals lines located at 522.68 eV were observed. Since the μXRF, 
EDX, and XPS had previously approved the presence of sulfur in the structure of catalyst, this 
result clearly suggested the absence of unreacted ClSO3H on the surface of the catalyst.  
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Fig. 9. XPS spectra of (a) Survey (inlet: Cl2p), and (b) S2p of nano catalyst 2. 
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After characterization of the catalyst, we studied its use in the synthesis of pyrido[2,3-
d]pyrimidines under nest conditions. Initially, an optimization of the reaction conditions (catalyst 
loading, temperature, and solvent) was carried out for the condensation between 4-
nitrobenzaldehyde, malononitrile and 2,4-diamino-6-hydroxypyrimidine at 100 ºC. As shown in 
Table 3, the best results were obtained when the reaction was performed in the presence of 2 mg 
of the catalyst (Table 3, entry 1). No yield improvement was observed using higher catalyst 
loadings (Table 3, entries 2 to 6). Table 3 clearly displays that in the absence of catalyst and 
different temperature 25 and 100 oC, the product was produced in low yields (Table 3, entry 7 and 
8). In addition, keeping the catalyst loading at 2 mg, lowers temperatures led to lower reaction 
yields (Table 3, entry 9 to 11). 
Table 3. Condensation of 4-nitrobenzaldehyde, malononitrile and 2,4-diamino-6-hydroxypyrimidine under neat 
conditions. Catalyst loading and temperature study.a 
 
Entry Catalyst loading (mg) Temperature (°C) Time (min) Yieldb (%) 
1 2 100 20 92 
2 2.5 100 22 92 
3 10 100 20 90 
4 30 100 25 87 
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To 
compare the effect of the solution in comparison with solvent-free conditions, a mixture of 4-
nitrobenzaldehyde, malononitrile and 2,4-diamino-6-hydroxypyrimidine as a typical reaction, by 
using 2 mg of nano [Fe3O4@SiO2@(CH2)3S-SO3H] as a catalyst in a good range of solvents such 
as H2O, MeCN, EtOH, EtOAC and CH2Cl2 were investigated under reflux condition. The results 
are summarized in Table 4. The results display that solvent-free condition was the best of choice 
for this reaction (Table 4, entry 6). 
Table 4. The effect of various solvents in the presence of 2 mg of [Fe3O4@SiO2@(CH2)3S-SO3H] as a catalyst in the 
one-pot condensation reaction of 4-nitrobenzaldehyde, malononitrile and 2,4-diamino-6-hydroxypyrimidine.a 
 
Entry Solvent Temperature Time Yieldb (%) 
5 50 100 20 80 
6 70 100 20 75 
7 - 110 180 20 
8 - 25 300 5 
9 2 25 120 20 
10 2 50 60 55 
11 2 80 60 90 
aReaction conditions: 4-nitrobenzaldehyde (1 mmol; 151 mg), malononitrile (1 mmol, 66 mg) and 2,4-
diamino-6-hydroxypyrimidine (1 mmol, 126 mg); bIsolated yield. 
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1 EtOAC Reflux 120 60 
2 MeCN Reflux 90 78 
3 EtOH Reflux 90 65 
4 CH2Cl2 Reflux 150 50 
5 H2O Reflux 60 90 
6 - Reflux 20 92 
Reaction condition: a4-nitrobenzaldehyde (1 mmol; 151 mg), malononitrile (1 mmol, 66 mg) and 2,4-diamino-6-
hydroxypyrimidine (1 mmol, 126 mg); bIsolated yield. 
After optimization of the reaction conditions, the efficiency and applicability of the method were 
studied via the reaction of malononitrile and 2,4-diamino-6-hydroxypyrimidine with various 
aromatic aldehydes in the presence of nano [Fe3O4@SiO2@(CH2)3S-SO3H]. The results are 
summarized in Table 5. Generally, all tested aldehydes including benzaldehyde as well as other 
aromatic aldehydes substituted with electron-donating and electron withdrawing groups afforded 
the desired pyrido[2,3-d]pyrimidine derivatives in good to excellent yields (84-94%) in short 
reaction times (8-23 min).  
Table 5. Synthesis of pyrido[2,3-d]pyrimidine derivatives under neat conditions at 100oC.a 
 
Entry Product Time (min) Yield (%)b M.p (°C) 
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Found and [Lit.]Ref. 
1 
N
H
HN
N
CN
NH2H2N
O
NO2
 
6a 13 87 
209-211 
[>300]12 
2 
 
6b 18 90 
216-218 
[-] 
 
3 
 
6c 13 92 
213-215 
[-] 
4 
 
6d 8 94 
272-274 
[-] 
5 
 
6e 11 92 
227-229 
[>300]12 
20 
 
6 
 
6f 12 90 
229-231 
[-] 
7 
 
6g 10 91 
220-222 
[-]12 
8 
 
6h 14 89 
235-237 
[>300]12 
9 
 
6i 13 91 
236-238 
[-] 
10 
 
6j 12 90 
266-268 
[-] 
21 
 
11 
 
6k 16 89 
233-235 
[>300]12 
12 
 
6l 19 86 
205-207 
[-] 
13 
 
6m 17 84 
223-225 
[>300]12 
14 
 
6n 22 86 
164-166 
[-] 
22 
 
15 
 
6o 20 89 
205-207 
[-] 
16 
 
6p 23 86 
213-215 
[-] 
aReaction conditions: arylaldehydes (1 mmol), malononitrile (1 mmol, 66 mg), 2,4-diamino-6-
hydroxypyrimidine(1 mmol, 126 mg) and [Fe3O4@SiO2@(CH2)3S-SO3H] (2 mg). b Isolated yield. 
A mechanistic proposal for the 2-catalyzed route towards the synthesis of pyrido[2,3-d]pyrimidine 
derivatives has been summarized in Scheme 3. According to the XPS results and previous works 
[12], the aldehyde, which is initially activated by the acidic surface sites of nano 
[Fe3O4@SiO2@(CH2)3S-SO3H], suffer a Knoevenagel condensation with malononitrile to give 
intermediate A. Then, this excellent Michael acceptor undergoes a conjugate addition reaction by 
2,4-diamino-6-hydroxypyrimidine to afford intermediate B that, after a 2-promoted intramolecular 
cyclization and a final tautomerization, affords the corresponding compounds 6 (Scheme 3). 
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Scheme 3. Proposed mechanism for the synthesis of pyrido[2,3-d]pyrimidines in the presence of 
[Fe3O4@SiO2@(CH2)3S-SO3H]. 
Catalyst recycling and recovering is an essential consideration regarding environmental, economic 
and industrial considerations. Apart from the magnetic isolation and separation of the catalyst upon 
reaction completion, the additional possibility to reuse it in several reaction cycles on the model 
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synthesis of 6a was also studied. Thus, after each cycle, the catalyst was magnetically separated 
from the reaction mixture and washed with a hot ethanol-water mixture and then, reused. As seen 
in Figure 10, the described catalyst can be reused up to 8 times without an important loss of 
activity. 
 
Fig. 10. Recyclability of nano[Fe3O4@SiO2@(CH2)3S-SO3H] in the synthesis 6a under neat conditions at 100 °C.  
Conclusion  
In conclusion, we have described the first catalytic synthesis of pyrido[2,3-d]pyrimidines using 
the novel and recoverable nano magnetic [Fe3O4@SiO2@(CH2)3S-SO3H] catalyst which has been 
fully characterized. The major advantages of this methodology are high yields, short reaction 
times, and reusability of the catalyst. The described results from this research supports the idea of 
rational designs, syntheses and applications of tasked-specific and reusable catalysts for the 
synthesis of polynitrogenated heterocyclic compounds containing the 1,4-dihydropyridine moietie. 
2. Experimental 
2.1. General information 
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Solvents and reagents were used as obtained from Sigma-Aldrich, Alfa Aesar, and Merck 
companies without further purification. Progress of the reactions was monitored by TLC using 
silica gel SIL G/UV 254 plates. Rf values were measured using EtOAc as solvent. Melting points 
were recorded on a Büchi B-545 apparatus in open capillary tubes. Fourier transformed infrared 
(FTIR) spectra of the catalyst and the synthesized products were recorded on a FTIR spectrometer 
Perkin-Elmer spectrum 65 using KBr disks. High resolution mass spectra (GC/QTOF, EI, 70 eV) 
were obtained using an Agilent 7200 Network spectrometer,. 1H NMR (300 and 400 MHz) spectra 
were obtained on a Bruker Avance 300 and a Bruker Avance 400 NMR spectrometers, under 
proton coupled mode using deuterated DMSO as a solvent, unless otherwise stated. 13C NMR (101 
MHz) spectra were acquired on a Bruker Avance 400 NMR spectrometer in the proton decoupled 
mode at 20 °C in deuterated DMSO as solvent, unless otherwise stated. Chemical shifts are given 
in δ (parts per million) and the coupling constants (J) in Hertz. 19F NMR (282 MHz) spectra were 
recorded on a Bruker Avance 300 NMR spectrometer, in proton coupled mode. Data for 1H NMR 
spectra is reported as follows: chemical shift (ppm), multiplicity (s, singlet; d, doublet; t, triplet; q, 
quartet; m, multiplet; and br., broad), coupling constant (Hz), and integration. Thermogravimetric 
analyses (TGA) were carried out on a Mettler Toledo equipment (model TGA/SDTA851 and 
/SF/1100 TGDTA) under nitrogen atmosphere at 25°C and using a heating rate of 25 °C min-1 up 
to 700 °C. Powder X-ray diffraction (XRD) pattern was recorded with an Ital structure ADD2000 
model, using a monochromatized Cu Kα (λ = 0.154 nm) X-ray source in the range 10° < 2θ < 80°. 
High resolution transmission electron microscopy (HRTEM) images were obtained using a JEOL 
JEM-2010 microscope operating at an accelerating voltage of 200 kv. Sample was prepared by 
drop casting the dispersed particles onto a 200-mesh copper grid coated with a holey carbon film. 
Scanning electron microscopy (SEM) studies were performed using a TESCAN/MIRA with a 
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maximum acceleration voltage of the primary electrons between 10 and 15 kV. N2 adsorption-
desorption isotherms were measured at 77 K with a Quantachrome NOVA 4000e analyzer. The 
Brunauer-Emmett-Teller (BET) method was used to calculate the specific surface areas (SBET). By 
using the Barrett-Joyner-Halenda (BJH) model, the pore volumes and pore size distributions were 
derived from the adsorption branches of isotherms. The micropore surface area (SBET micro) was 
calculated using the V-t plot method. X-ray photoelectron spectroscopy (XPS, K-ALPHA, Thermo 
Scientific) was used to analyze the samples surface. All spectra were collected using Al-K 
radiation (1486.6 eV), monochromatized by a twin crystal monochromator, yielding a focused X-
ray spot (elliptical in shape with a major axis length of 400µm) at 3 mA × 12 kV. XPS data were 
analyzed using Thermo Scientific Avantage Software. A smart background function was used to 
approximate the experimental backgrounds and surface elemental composition was calculated 
from background-subtracted peak areas. Charge compensation was achieved with the system flood 
gun that provides low energy electrons and low energy argon ions from a single source. A 
Gaussian/Lorenzian product function peak shape model (L/G Mix (%) = 30) was used. Micro X-
ray fluorescence (µXRF) analyses were performed on an Edax, Orbis using 25 kV with image 
mapping resolution (128 × 100). 
Prapration of nano[Fe3O4@SiO2@(CH2)3S-SO3H] catalyst  
Initially, iron oxide (Fe3O4) magnetic nanoparticles and the silica coated on iron oxide 
(Fe3O4@SiO2) were synthesized according to previously reported procedures [24]. Thus, in a 
round-bottomed flask, 1.0 g of previously dried (under vacuum) silica coated magnetic 
nanoparticles was dispersed in 50 mL of anhydrous toluene and it was sonicated for 30 min.  
After this time, 3.5 mL of 3-(trimethoxysilyl)-1-propanethiol were added dropwise to the 
suspended solid nanoparticles, being the obtained mixture refluxed under mechanical stirring 
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for 24 h. After this time, the prepared nanoparticles 1 were isolated by using an external magnet 
and dried at room temperature. Then, in a round-bottomed flask, 1.0 g of 
[Fe3O4@SiO2@(CH2)3SH] (1) was sonicated for 30 min in anhydrous CH2Cl2 (50 mL). Next, 
0.5 mL of cholorosulfunic acid were added dropwise to the reaction mixture at room 
temprature and the resulting solution was allowed to stirr for 2 h until no more hydrogen 
chloride evolution was detected. Then, the resulting mixture was isolated by using an external 
magnet to afford [Fe3O4@SiO2@(CH2)3S-SO3H] (2) which was washed with ethanol and dried 
at room temperature (Scheme 1). 
General procedure for the synthesis of pyrido[2,3-d]pyrimidine derivatives  
In a 10 mL round-bottomed flask, a mixture of aldehyde (1 mmol), malononitrile (1 mmol, 66 mg), 
2,4-diamino-6-hydroxypyrimidine (1 mmol, 126 mg), and [Fe3O4@SiO2@(CH2)3S-SO3H] (2 mg) 
were stirred at 100 °C under neat conditions. After completion of the reaction (monitored by TLC), 
the mixture was allowed to cool to room temperature. Then, the resulted solid mixture was solved 
in DMF and the catalyst was recovered using a magnet. Products precipitated out of the DMF 
solution. Finally, the obtained crystals were washed with water to remove DMF (Table 1) (Scheme 
2). 
2,7-Diamino-5-(4-nitrophenyl)-4-oxo-3,4,5,8-tetrahydropyrido[2,3-d]pyrimidine-6-
carbonitrile (6a): 
Isolated as yellow solid, (283 mg, 87%), Rf: 0.16, Melting point: 209 – 211 °C; FT-IR: υ (cm-1) = 
3471, 3385, 3348, 3167, 2191, 1666, 1630, 1555, 1516, 1455, 1394, 1346, 1204; 1H NMR: δ 8.19 
(d, J = 8.7, 2H), 7.45 (d, J = 8.7, 2H), 7.08 (br. s, 2H), 6.27 (br. s, 2H), 6.17 (br. s, 2H), 4.62 (s, 
1H); 13C NMR: δ 163.2, 162.4, 162.2, 160.5, 152.8, 146.8, 128.7, 124.2, 120.4, 84.5, 57.1, 35.7; 
HRMS calcd. for C10H5N3O2 [M+ - (C4H6N4O)] 199.0382, found 199.0383. 
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2,7-Diamino-4-oxo-5-phenyl-3,4,5,8-tetrahydropyrido[2,3-d]pyrimidine-6-carbonitrile (6b): 
Isolated as khaki solid, (252 mg, 90%), Rf: 0.65, Melting point: 216 – 218 °C; FT-IR: υ (cm-1) = 
3491, 3384, 3169, 2183, 1662, 1465, 1394, 1201, 1132; 1H NMR: δ 7.33 – 7.26 (m, 2H), 7.25 – 
7.17 (m, 3H), 6.91 (br. s, 2H), 6.15 (br. s, 2H), 6.09 (br. s, 2H), 4.41 (s, 1H); 13C NMR (75 MHz) 
δ 163.2, 162.1 (2c), 160.3, 145.2, 128.9, 127.4, 127.2, 120.8, 85.7, 58.6, 35.9; HRMS calcd. for 
C10H6N2 [M+ - (C4H6N4O)] 154.0531, found 154.0537. 
2,7-Diamino-5-(3,4-difluorophenyl)-4-oxo-3,4,5,8-tetrahydropyrido[2,3-d]pyrimidine-6-
carbonitrile (6c):  
Isolated as lemon chiffon solid, (290 mg, 92%), Rf: 0.30, Melting point: 213 – 215 °C; FT-IR: υ 
(cm-1) = 3480, 3403, 3328, 3154, 2929, 2185, 1656, 1634, 1556, 1459, 1395, 1286, 1140, 799; 1H 
NMR: δ 7.43 – 7.32 (m, 1H), 7.26 – 7.17 (m, 1H), 7.11 – 6.90 (m, 3H), 6.23 (br. s, 2H), 6.14 (br. 
s, 2H), 4.45 (s, 1H); 13C NMR: δ 163.1, 162.3, 162.0, 160.4, 149.50 (dd, J = 246.0, 12.8 Hz), 
148.65 (dd, J = 245.0, 12.6 Hz), 143.0 (t, J = 3.5), 124.0 (m), 120.6, 118.0 (d, J = 17.1), 116.0 (d, 
J = 17.1), 84.9, 57.7, 35.2; 19F NMR: δ -136.58 (d, J = 22.5 Hz), -139.17 (d, J = 22.5 Hz); HRMS 
calcd. for C10H4F2N2 [M+ - (C4H6N4O)] 190.0343, found 190.0344. 
2,7-Diamino-5-(2,6-difluorophenyl)-4-oxo-3,4,5,8-tetrahydropyrido[2,3-d]pyrimidine-6-
carbonitrile (6d):  
Isolated as floral white solid, (297 mg, 94%), Rf: 0.20, Melting point: 272 – 274 °C; FT-IR: υ (cm-
1) = 3478, 3377, 3181, 2193, 1665, 1621, 1469, 1392, 1208, 995, 782, 563; 1H NMR: δ 7.41 – 7.28 
(m, 1H), 7.17 – 6.93 (m, 4H), 6.18 (br. s, 2H), 5.75 (br. s, 2H), 4.89 (s, 1H); 13C NMR: δ 163.1, 
162.3, 162.2 (dd, J = 240, 20), 161.3, 154.5, 129.8 (t, J = 10.6), 120.4, 119.0 (t, J = 15.9), 112.4 
(d, J = 24.7), 83.4, 54.2, 26.2; 19F NMR (282 MHz) δ -106.83, -114.09; HRMS calcd. for 
C10H4F2N2 [M+ - (C4H6N4O)] 190.0343, found 190.0350. 
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2,7-Diamino-5-(4-bromophenyl)-4-oxo-3,4,5,8-tetrahydropyrido[2,3-d]pyrimidine-6-
carbonitrile (6e): 
Isolated as moccasin solid, (329 mg, 92%), Rf: 0.16, Melting point: 227 – 229 °C; FT-IR: υ (cm-
1) = 3466, 3391, 3173, 2184, 1661, 1625, 1553, 1384, 1298, 1132; 1H NMR: δ 7.53 – 7.47 (m, 
2H), 7.19 – 7.12 (m, 2H), 6.97 (br. s, 2H), 6.20 (br. s, 2H), 6.12 (br. s, 2H), 4.43 (s, 1H); 13C NMR: 
δ 163.1, 162.2, 162.1, 160.3, 144.6, 131.7, 129.7, 120.7, 120.2, 85.2, 57.9, 35.4; HRMS calcd. for 
C10H5BrN2 [M+ - (C4H6N4O)] 231.9636 and 233.9616, found 231.9645 and 233.9620. 
2,7-Diamino-5-(3-bromophenyl)-4-oxo-3,4,5,8-tetrahydropyrido[2,3-d]pyrimidine-6-
carbonitrile (6f): 
Isolated as linen solid, (323 mg, 90%), Rf: 0.30, Melting point: 229 – 231 °C; FT-IR: υ (cm-1) = 
3491, 3381, 3182, 2193, 1668, 1619, 1553, 1448, 1388, 1295, 1130, 1070, 786; 1H NMR: δ 7.45 
– 7.38 (m, 2H), 7.28 (t, J = 7.9, 1H), 7.16 (d, J = 7.5, 1H), 7.01 (br. s, 2H), 6.25 (br. s, 2H), 6.15 
(br. s, 2H), 4.43 (s, 1H); 13C NMR: δ 163.1, 162.3, 162.1, 160.4, 148.0, 131.2, 130.1 (2c), 126.5, 
122.0, 120.6, 85.0, 57.8, 35.5; HRMS calcd. for C10H5BrN2 [M+ - (C4H6N4O)] 231.9636 and 
233.9616, found 231.9638 and 233.9615. 
2,7-diamino-5-(4-chlorophenyl)-4-oxo-3,4,5,8-tetrahydropyrido[2,3-d]pyrimidine-6-
carbonitrile (6g): 
Isolated as khaki solid, (mg, 91%), Rf: 0.65, Melting point: 220 – 222 °C; FT-IR: υ (cm-1) = 3492, 
3379, 3331, 3178, 2929, 2194, 1669, 1618, 1552, 1449, 1391, 1297, 1131, 828; 1H NMR: δ 7.40 
– 7.33 (m, 2H), 7.25 – 7.18 (m, 2H), 6.96 (br. s, 2H), 6.19 (br. s, 2H), 6.12 (br. s, 2H), 4.44 (s, 
1H); 13C NMR: δ 163.1, 162.2, 162.1, 160.3, 144.2, 131.7, 129.3, 128.8, 120.7, 85.2, 58.0, 35.3; 
HRMS calcd. for C10H5ClN2 [M+ - (C4H6N4O)] 188.0141 and 190.0112, found 188.0145 and 
190.0113. 
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2,7-Diamino-5-(2-chlorophenyl)-4-oxo-3,4,5,8-tetrahydropyrido[2,3-d]pyrimidine-6-
carbonitrile (6h):  
Isolated as papaya whip solid, (279 mg, 89%), Rf: 0.40, Melting point: 235 – 237 °C; FT-IR: υ 
(cm-1) = 3473, 3395, 3322, 3165, 2191, 1666, 1629, 1558, 1456, 1394, 1299, 1138, 1035, 750; 1H 
NMR: δ 7.41 – 7.23 (m, 4H), 6.97 (br. s, 2H), 6.15 (br. s, 2H), 5.74 (br. s, 2H), 4.76 (s, 1H); 13C 
NMR (75 MHz) δ 163.1, 162.2 (2c), 160.6, 140.7, 132.4, 131.4, 130.6, 129.3, 128.1, 120.3, 84.3, 
56.1, 35.2; HRMS calcd. for C10H5ClN2 [M+ - (C4H6N4O)] 188.0141 and 190.0112, found 
188.0145 and 190.0112. 
2,7-Diamino-5-(4-cyanophenyl)-4-oxo-3,4,5,8-tetrahydropyrido[2,3-d]pyrimidine-6-
carbonitrile (6i): 
Isolated as khaki solid, (277 mg, 91%), Rf: 0.17, Melting point: 236 – 238 °C; FT-IR: υ (cm-1) = 
3451, 3413, 3337, 3204, 2885, 2731, 2227, 1633, 1594, 1442, 1395, 817; 1H NMR: δ 10.06 (br. s, 
1H), 7.89 – 7.72 (m, 4H), 6.49 (br. s, 2H), 6.38 – 6.15 (m, 3H), 4.72 (d, J = 11.5, 1H); 13C NMR: 
δ 163.2, 162.6, 154.6, 145.6, 132.6, 129.2, 119.2, 114.9, 114.6, 110.6, 84.3, 42.6, 25.9; HRMS 
calcd. for C11H5N3 [M+ - (C4H6N4O)] 179.0483, found 179.0486. 
2,7-Diamino-5-(2,6-dichlorophenyl)-4-oxo-3,4,5,8-tetrahydropyrido[2,3-d]pyrimidine-6-
carbonitrile (6j): 
Isolated as white solid, (314 mg, 90%), Rf:  0.22, Melting point: 266 – 268 °C; FT-IR: υ (cm-1) = 
3479, 3377, 3319, 3181, 2193, 1670, 1621, 1469, 1394, 1208, 995, 782; 1H NMR: δ 7.55 (d, J = 
7.8, 1H), 7.44 (d, J = 7.8, 1H), 7.35 (t, J = 8.0, 1H), 7.05 (s, 2H), 6.20 (s, 2H), 5.42 (br. s, 2H), 
5.32 (s, 1H); 13C NMR δ 162.8, 162.3, 161.2, 135.8, 134.7, 131.8, 130.3, 129.2, 119.8, 82.7, 53.1, 
33.6; HRMS calcd. for C10H4Cl2N2 [M+ - (C4H6N4O)] 221.9752 and 223.9722 and 225.9693 found 
221.9754 and 223.9720 and 225.9694. 
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2,7-Diamino-5-(3-nitrophenyl)-4-oxo-3,4-dihydropyrido[2,3-d]pyrimidine-6-carbonitrile 
(6k):  
Isolated as pale golden rod solid, (287 mg, 89%), Rf: 0.16, Melting point: 233 – 235 °C; FT-IR: υ 
(cm-1) = 3496, 3466, 3400, 3121, 2917, 2187, 1674, 1634, 1594, 1536, 1351, 1148, 787; 1H NMR: 
δ 8.18 – 8.05 (m, 2H), 7.72 – 7.52 (m, 2H), 7.08 (br. s, 2H), 6.31 (br. s, 2H), 6.17 (br. s, 2H), 4.63 
(s, 1H); 13C NMR: δ 163.1, 162.4, 162.2, 160.6, 148.1, 147.6, 134.2, 130.6, 122.4, 121.9, 120.5, 
84.7, 57.4, 35.5; HRMS calcd. for C10H5N3O2 [M+ - (C4H6N4O)] 199.0382, found 199.0383. 
2,7-Diamino-5-(4-methoxyphenyl)-4-oxo-3,4,5,8-tetrahydropyrido[2,3-d]pyrimidine-6-
carbonitrile (6l): 
Isolated as yellow solid, (266 mg, 86%), Rf: 0.29, Melting point: 205 – 207 °C; FT-IR: υ (cm-1) = 
3400, 2186, 1659, 1626, 1556, 1455, 1384, 1034; 1H NMR: δ 7.11 (d, J = 8.7, 2H), 6.87 – 6.83 
(m, 4H), 6.11 (br. s, 2H), 6.06 (br. s, 2H), 4.35 (s, 1H), 3.72 (s, 3H); 13C NMR: δ 163.1, 162.1, 
161.9, 160.1, 158.5, 137.3, 128.5, 120.8, 114.2, 85.9, 58.8, 55.5, 35.1; HRMS calcd. for C11H8N2O 
[M+ - (C4H6N4O)] 184.0637, found 184.0638. 
2,7-Diamino-4-oxo-5-(p-tolyl)-3,4,5,8-tetrahydropyrido[2,3-d]pyrimidine-6-carbonitrile 
(6m):  
Isolated as ivory solid, (247 mg, 84%), Rf: 0.18, Melting point: 223 – 225 °C; FT-IR: υ (cm-1) = 
3473, 3399, 3321, 3165, 2193, 2175, 1655, 1625, 1456, 1392, 1297, 1199, 1039, 792; 1H NMR: δ 
7.09 (s, 4H), 6.87 (s, 2H), 6.10 (br. s, 2H), 6.07 (br. s, 2H), 4.36 (s, 1H), 2.25 (s, 3H); 13C NMR: δ 
163.2, 162.1, 162.0, 160.1, 142.2, 136.3, 129.4, 127.4, 120.8, 85.8, 58.7, 35.6, 21.1; HRMS calcd. 
for C11H8N2 [M+ - (C4H6N4O)] 168.0687, found 168.0684. 
2,7-Diamino-5-(4-hydroxyphenyl)-4-oxo-3,4,5,8-tetrahydropyrido[2,3-d]pyrimidine-6-
carbonitrile (6n): 
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Isolated as papaya whip solid, (254 mg, 86%), Rf: 0.23, Melting point: 164 – 166 °C; FT-IR: υ 
(cm-1) = 3446, 3345, 3184, 2195, 1660, 1618, 1552, 1463, 1388, 1260, 664; 1H NMR: δ 9.28 (br. 
s, 1H), 6.99 (d, J = 8.5, 2H), 6.82 (br. s, 2H), 6.67 (d, J = 8.5, 2H), 6.05 (br. s, 4H), 4.28 (s, 1H); 
13C NMR: δ 163.1, 162.0, 161.9, 160.0, 156.6, 135.5, 128.5, 120.9, 115.5, 86.1, 59.1, 35.2; HRMS 
calcd. for C10H6N2O [M+ - (C4H6N4O)] 170.0480, found 170.0483. 
2,7-Diamino-5-(3-ethoxy-4-hydroxyphenyl)-4-oxo-3,4,5,8-tetrahydropyrido[2,3-
d]pyrimidine-6-carbonitrile (6o): 
Isolated as beige solid, (303 mg, 89%), Rf: 0.33, Melting point: 205 – 207 °C; FT-IR: υ (cm-1) = 
3500, 3472, 3361, 3161, 2975, 2195, 1673, 1646, 1627, 1560, 1468, 1377, 1286, 1119, 1032; 1H 
NMR: δ 8.77 (s, 1H), 6.82 (br. s, 3H), 6.69 (d, J = 8.1, 1H), 6.52 (dd, J = 8.1, 2.0, 1H), 6.05 (br. s, 
4H), 4.26 (s, 1H), 4.05 – 3.88 (m, 2H), 1.31 (t, J = 7.0, 3H); 13C NMR: δ 163.2, 161.9 (2c), 159.9, 
146.7, 146.1, 136.1, 120.9, 119.7, 116.1, 113.6, 86.0, 64.4, 59.0, 35.6, 15.2; HRMS calcd. for 
C12H10N2O2 [M+ - (C4H6N4O)] 214.0742, found 214.0747. 
2,7-Diamino-4-oxo-5-(thien-2-yl)-3,4,5,8-tetrahydropyrido[2,3-d]pyrimidine-6-carbonitrile 
(6p): 
Isolated as papaya whip solid, (246 mg, 86%), Rf: 0.12, Melting point: 213 – 215 °C; FT-IR: υ 
(cm-1) = 3486, 3376, 3152, 2193, 1669, 1622, 1556, 1451, 1398, 1126, 793, 728; 1H NMR: δ 7.33 
(dd, J = 5.1, 1.1, 1H), 7.07 – 6.95 (m, 3H), 6.93 – 6.88 (m, 1H), 6.35 (br. s, 2H), 6.12 (br. s, 2H), 
4.82 (s, 1H); 13C NMR: δ 163.1, 162.1, 161.6, 160.5, 150.6, 127.0, 125.0, 124.7, 120.7, 86.0, 58.5, 
31.4; HRMS calcd. for C8H4N2S [M+ - (C4H6N4O)] 160.0095, found 160.0097. 
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